St. Jude Medical Inc. is on pace to meet or exceed its previous 2013 revenue target for its cardiac rhythm management devices business, the company announced during its July 17 second-quarter earnings call.
The CRM business includes all of St
St. Jude Medical: Cardiac Rhythm Management Business Has “Turned The Corner”
The firm reported during its second-quarter earnings call that its cardiac rhythm management business has stabilized after several quarters of market share decline.